Intra-Asia air freight capacity tightens on US high-tech demand
The growth in traffic on intra-Asian routes is a result of ongoing US demand for cloud infrastructure logistics related to the rapid development of AI technology. Continue reading →
Digital forwarder owned by Bolloré merges with French forwarding group
The merger will see Fatton & Lyseo use Ovrsea’s proprietary operating software across its air and sea customers in Asia, Africa and North America. Continue reading →
Optimistic outlook sets multipurpose sector on firm footing for 2026
This year’s positive MPV forecast is bolstered by a high level of forward bookings and the prospect of postponed projects coming onstream. Continue reading →
How can utilities improve their distribution planning for better resiliency and restoration?
Contributor Jason Endsley asks the question: How do we build, maintain, and—when things go wrong—restore the system faster and more reliably with the resources we have? Continue reading →
Pattern Energy obtains 1,500-MW portfolio with Cordelio acquisition
Pattern will acquire a 1,550-MW operating and in-construction portfolio from Cordelio comprised of 16 wind, solar and storage projects in North America. Continue reading →
New bill could make solar power more accessible to Maine renters
Maine lawmakers are considering LD 1730, proposed by State Sen. Nicole Grohoski, to allow renters to use plug-in solar units to lower electricity costs. Continue reading →
When the local pharmacovigilance lead becomes a business protection role
Pharmacovigilance failures tend to surface publicly only when something goes wrong. A delayed safety signal, an inspection finding or a post market correction can quickly escalate into reputational and financial consequences for drugmakers. Against that backdrop, shifting regional expectations are forcing companies to reconsider how local pharmacovigilance responsibilities...
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Treating obesity may directly improve psoriatic arthritis outcomes, according to Phase 3b data released Wednesday by Eli Lilly. In the TOGETHER-PsA trial, patients receiving both Zepbound (tirzepatide) and Taltz (ixekizumab) showed a 64% relative improvement in arthritis disease activity compared to those on Taltz alone. The findings suggest obesity treatment directly...
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Merck is an A+ credit, a global oncology powerhouse, and still, about half its 2024 pharma revenue came from a single product: Keytruda, a product whose loss of exclusivity will hit around 2028 in the U.S. S&P Global Ratings calls that kind of concentration a “material weakness.” Merck isn’t alone. A new S&P analysis of… The post S&P report...
Rural health’s $50B moment – or missed opportunity?
States are beginning to sketch out plans to deploy billions of dollars in new federal funding aimed at stabilizing and transforming rural healthcare, but early signals point to wide variation in approach and persistent uncertainty for rural hospitals waiting to understand when, how and whether funds will reach local providers. CMS awarded $50 billion across all 50 states...
Healthcare job growth slows: 4 notes
Healthcare employment continued to grow in December, with the industry adding 21,100 jobs, according to the latest report from the U.S. Bureau of Labor Statistics. BLS released the December jobs report Jan. 9. Here are three more takeaways: 1. December’s healthcare job growth fell below the industry’s average monthly gain of 34,000 in 2025 — and below the 2024...
